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Abstract
Background: The predictive ability of National Institute of Neurological Disease and Stroke-Canadian Stroke Network
(NINDS-CSN) 5-minute protocol and Montreal Cognitive Assessment (MoCA) administered sub-acutely and at the
convalescent phase after stroke for significant vascular cognitive impairment (VCI) at 1 year is unknown. We compared
prognostic values of these tests.
Methods: Patients with ischemic stroke and transient ischemic attack (TIA) received MoCA sub-acutely (within 2 weeks)
and 3–6 months after stroke followed by a formal neuropsychological evaluation at 1 year. The total score of NINDS-
CSN 5-minutes protocol was derived from MoCA. Moderate-severe VCI was defined as neuropsychological impairment
in ≥ 3 domains. Area under the receiver operating characteristic curve (AUC) analyses were conducted to establish the
optimal cutoff points and discriminatory properties of the MoCA and NINDS-CSN 5-minute protocol in detecting
moderate-severe VCI.
Results: Four hundre patients were recruited at baseline. Of these, 291 received a formal neuropsychological assessment
1 year after stroke. 19 % patients had moderate-severe VCI. The MoCA was superior to the NINDS-CSN 5-minute protocol
[sub-acute AUCs: 0.89 vs 0.80, p < 0.01; 3–6 months AUCs: 0.90 vs 0.83, p < 0.01] in predicting for moderate-severe VCI at
1 year. At respective cutoff points, MoCA had significantly higher sensitivity than the NINDS-CSN 5-minute protocol at
baseline (p = 0.01) and 3–6 months (p = 0.04).
Conclusions: MoCA administered sub-acutely and 3–6 months after stroke is superior to the NINDS-CSN 5-minute
protocol in predicting moderate-severe VCI at 1 year.
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Background
Post-stroke vascular cognitive impairment (VCI) at 3–6
months after stroke is common (57.7 %) in Asian patients
with mild stroke and transient ischemic attack (TIA) [1].
Approximately 25 % of stroke/TIA patients had moderate-
severe VCI of sufficient severity to place them at a higher
risk for cognitive decline [1, 2]. Therefore, early detection
of patients with moderate-severe VCI in the subacute
stroke phase (initial 2 weeks after stroke) is required for
intensive reduction of vascular risk factors and improve
prognosis [3].
We have previously established that the commonly used
brief screening instruments, i.e., the Mini-Mental State
Examination (MMSE) and Montreal Cognitive Assess-
ment (MoCA), administered at the subacute stroke phase
can predict moderate-severe VCI 3–6 months after stroke
with good sensitivity, as determined by formal neuro-
psychological evaluations [1], which has been replicated
[4]. Note that patients with the highest education level of
primary school or below would award 1-point for MoCA.
However, both the MoCA and MMSE take approximately
10–12 min to administer, and may not be practical for
bedside screening, especially during acute stroke admis-
sion. By contrast, the National Institute of Neurological
Disease and Stroke-Canadian Stroke Network (NINDS-
CSN) 5-minute protocol drawn from the MoCA takes less
time and has been recommended for bedside screening
[5]. Two studies examined the NINDS-CSN 5-minute
protocol for post-stroke VCI screening in person or
over the phone and showed conflicting results [6, 7].
One study reported that NINDS-CSN 5-minute proto-
col performed less well than the MoCA [6], while the
other reported both tests to be equivalent in detecting
post-stroke VCI [7]. These inconsistent findings could
be due to different scoring methods (total score of 12
and 30 respectively) and diagnosis of VCI (modified
Petersen’s criteria for mild cognitive impairment and
cognitive impairment defined by Clinical Dementia
Rating scale respectively). Additionally, the predictive
ability of NINDS-CSN 5-minute protocol for post-stroke
moderate-severe VCI remains unknown. We therefore
aimed to: 1) examine whether the MoCA and NINDS-
CSN 5-minute protocol administered at subacute stroke
phase and 3–6 months later could predict moderate-severe
VCI at 1 year; and 2) compare discriminatory abilities of
these two tests using their respective optimal cutoff points.
The MoCA administered at baseline has been re-
ported to be predictive of moderate-severe VCI at 3–6
months after stroke/TIA [1]. Additionally, the NINDS-
CSN 5-minute protocol was drawn from the MoCA
items. Therefore, we hypothesized that the MoCA and
NINDS-CSN 5-minute protocol administered at baseline
and 3–6 months after stroke would be equivalent, sensi-
tive, and predictive of moderate-severe VCI at 1 year.
Methods
Subjects
We recruited 400 consecutive patients (≥21 years old) with
a recent ischemic stroke or TIA during the sub-acute
stroke phase at the National University Hospital, Singapore.
Patients were excluded if they had a major physical disabil-
ity or an active psychiatric disorder that would impede
cognitive testing. Eligible patients were assessed at baseline,
i.e., within 2 weeks after their cerebrovascular event, 3–6
months and 12 months after stroke/TIA. At baseline their
demographic and clinical outcome measures were collected
along with cognitive status measured by brief cognitive test
the MoCA. At 3–6 months and 12 months after stroke/
TIA, their clinical outcome measures and neuropsycho-
logical performance on a formal test battery were collected.
The availability of an informant was required for a patient
to be included in the study.
Standard protocol approvals and patient consent
This study was approved by the National Healthcare
Group Domain-Specific Review Board (DSRB), and was
conducted in conformity with the Declaration of Helsinki.
Written informed consent was obtained from all partici-
pants and/or their legally acceptable representatives.
Procedures
Baseline characteristics
Demographic information (age, gender, ethnicity, years
of education), clinical information, vascular risk factors,
and neurological status i.e. National Institute of Health
Stroke Score (NIHSS) and modified Rankin Scale (mRS)
were collected.
Clinical outcome measures
Patients were followed up at 3–6 months and 1 year after
their index cerebrovascular event for their neurological sta-
tus, clinical outcomes and interval events. Medical records
were used to verify these events (strokes or TIA, peripheral
artery disease, intracranial hemorrhage, cardiovascular risk
factor, cardiac events or deaths from any of the above).
Cognitive measures
Patients’ cognitive status was assessed by the MoCA at
baseline and 3–6 months after stroke. The MoCA has 12
items with a maximum score of 30. It consists of seven
subtests: visuo-executive, naming, attention, language, ab-
straction, delayed recall and orientation. The MoCA was
modified for Singaporean population such as replacing a
test of letter fluency with semantic fluency (animals). Pa-
tients with a highest education level of primary school or
below would receive an additional 1-point as education
adjustment in MoCA scores. Details of MoCA modifica-
tion can be found in our previous paper [8]. The NINDS-
CSN 5-minute test protocol consists of three individual
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test items, i.e., 5-word recall (5 points), 6-item orienta-
tion (6 points), and verbal fluency [1 point if >10 words
(animals) are generated in 60 s], drawn from the MoCA
with a maximum score of 12 [5]. Brief description of
these two tests were covered in [9]. Patients also re-
ceived a formal neuropsychological battery covering
seven domains locally validated for Singaporean elderly
at 12 months after stroke [10], which was administered
by trained research psychologists blinded to the baseline
MoCA scores. The formal neuropsychological battery
(Additional file 1: Table S1) has been locally validated for
Singaporean and was used in stroke clinical research [1, 2,
10]. It consists of domains in executive function, attention,
language, visuoconstruction, visuomotor speed, verbal and
visual memory. This formal neuropsychological battery was
used to define cognitive impairment. Age and education-
adjusted cutoffs of 1.5 standard deviations (SD) below the
established norms were used on individual tests. A result of
at least half the tests failing in a domain defines domain
impairment. The neuropsychological findings were inter-
preted by a doctoral level neuropsychologist (YD) to estab-
lish cognitive impairment. Patients with vascular cognitive
impairment no dementia (VCIND) were those with object-
ive cognitive domain impairment determined by the neuro-
psychological test battery without meeting the criteria
for dementia. VCIND patients were further classified
into VCIND mild (≤ 2 impaired domains) and VCIND
moderate (≥ 3 impaired domains) [2]. VCI patients
were dichotomized into no–mild VCI (no cognitive im-
pairment (NCI) and VCIND mild) and moderate–se-
vere VCI (VCIND moderate and dementia). Diagnoses
of dementia were made according to the Diagnostic
and Statistical Manual of Mental Disorders [11]. The
Bayer-Activities of Daily Living Scale [12] was adminis-
tered to the informant to ascertain functional disabil-
ities primarily due to cognitive impairment.
Statistical analyses
Data analysis was conducted using Statistical Package R
version 3.2.0. Receiver operating characteristic (ROC) curve
analyses were conducted to establish the optimal cutoff
points and discriminatory properties of the MoCA and
NINDS-CSN 5-minute protocol in detecting moderate-
severe VCI. The optimal cutoff points were chosen by
Youden Index [13]. Area under the operating characteris-
tics curves (AUCs) of these tests were compared statistically
[14]. Additionally, McNemar’s test was employed to com-
pare sensitivities at the optimal cutoff points of the MoCA
and NINDS-CSN 5-minute protocol.
Results
Subject characteristics
Recruited patients were mostly Chinese (70.3 %) and
male (69.8 %), with a mean age of 59.8 ± 11.6 years and a
mean of 7.7 ± 4.3 years of formal education. A majority
of subjects had mild stroke (NIHSS ≤ 2, n = 233, 58.5 %)
and minimal disability (mRS ≤ 2, n = 251, 63 %). Of 319
ischemic stroke patients classified using the TOAST
criteria [15], most (n = 179, 44.8 %) patients had small
artery occlusion, with a further 15.0 % (n = 60) with large
artery atherosclerosis, 14.8 % (n = 59) with cardio-
embolism, 5.3 % (n = 21) with undetermined or other deter-
mined etiology.
Two hundred ninety one out of 400 stroke/TIA pa-
tients completed a formal neuropsychological assess-
ment at 1 year after stroke. Of these, 56 (19 %) had
moderate-severe VCI (Table 1). Patients with moderate-
severe VCI were older with lower education level and
had higher NIHSS scores. Patients who were lost to
follow-up at 1 year (n = 109) did not have significantly
different baseline characteristics from those who com-
pleted follow-up.
Comparison of the predictive ability of the MoCA and
NINDS-CSN 5-minute protocol
Figures 1 and 2 shows that the MoCA had statistically
larger AUCs than the NINDS-CSN 5-minute protocol
sub-acutely [AUC (95 % CI): 0.89 (0.85–0.93) vs 0.80
(0.74–0.87), p <0.01] and 3–6 months after stroke [AUC
(95 % CI): 0.90 (0.86–0.94) vs 0.83 (0.77–0.89), p <0.01]
for detecting patients with moderate-severe VCI at
1 year. ROC analyses repeated using age- and education-
adjusted scores did not alter the results.
Table 2 shows the discriminatory properties of the
MoCA and NINDS-CSN 5-minute protocol sub-acutely
and at 3–6 months for predicting moderate-severe VCI at
1 year after stroke. At respective optimal cut-off points at
baseline, the MoCA (<20) was superior to NINDS-CSN
5-minute protocol (<8) (p < 0.01). McNemar’s tests showed
that the sensitivities of MoCA (<20) was significantly higher
than NINDS-CSN 5-minute protocol (<8) (p = 0.01). At the
respective optimal cutoff points at 3–6 months after stroke,
the MoCA (<21) was equivalent to NINDS-CSN 5-minute
protocol (<8) (p = 0.07). Additionally, the MoCA (<21) had
significantly higher sensitivity than NINDS-CSN 5-minute
protocol (<8) (p = 0.04). Moreover, we excluded participants
who experienced at recurrent vascular event between base-
line and 1 year follow up, and repeated the ROC analysis,
however, results remained the same.
Discussion
The principal finding of this study is that MoCA admin-
istered in the subacute stroke phase and 3–6 months
later, is more sensitive and superior to the NINDS-CSN
5-minute protocol in predicting moderate-severe VCI at
1 year, as determined by formal neuropsychological
evaluations.
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Our finding, that the MoCA administered at baseline
is predictive of moderate-severe VCI at 1 year, is con-
sistent with previous studies [1, 4]. Our finding that
the MoCA at baseline and 3–6 months after stroke are
more sensitive and superior to NINDS-CSN 5-minute
protocol in detecting moderate-severe VCI at 1 year
later is consistent with a previous study [6], although
that study did not compare the AUCs of MoCA to
NINDS-CSN using inferential statistics. Our finding
differs from a recent study [7] due to different scoring
method (the initial scoring method of 12 points in the
present study vs. 30 points in the previous study).
Additionally, the NINDS-CSN 5-minute protocol at its
optimal cutoff point (<8) at baseline or 3-6 months
had similar sensitivity to the findings reported by Bocti
et al [16] (0.73, 0.70, and 0.72 respectively) [16]. How-
ever the specificity of the NINDS-CSN 5-minute
protocol in the present study is somewhat lower than
the previous findings by Bocti et al (0.75, 0.83, and
0.91 respectively). This could be due to different gold
standard criteria to define cognitive impairment, i.e., a
formal neuropsychological evaluation was used in the
present study while MoCA < 26 was used to define
cognitive impairment by Bocti and colleagues. The use
of MoCA cutoff points to define cognitive impairment
may have inflated the value of specificity. In view of a
higher sensitivity and negative predictive value (NPV)
of the MoCA relative to NINDS-CSN 5-minute test at
optimal cutoff points (baseline sensitivity: 0.88 vs 0.73,
NPV: 0.96 vs 0.92; 3–6 months sensitivity 0.83 vs 0.70,
NPV: 0.95 vs 0.92), MoCA administered at baseline
and 3–6 months after stroke would be better than the
NINDSCSN 5-minute protocol in predicting for
moderate-severe VCI at 1 year.
One limitation of the present study is that our sample
consisted of mild stroke/TIA patients, therefore results
may not be generalizable to all stroke populations.
Nevertheless, approximately 1/5 of this milder stroke
group had moderate-severe VCI at 1 year after stroke
who may escape clinical attention without early
Table 1 Sample characteristics
Characteristics No-mild VCI (n = 235) Moderate-severe VCI (n = 56) Univariate Analysis p
Age, mean (SD) 57.46 (10.20) 68.43 (11.23) <0.01
Gender, female 64 (27 %) 21 (38 %) 0.18
Education, y (mean, SD) 8.33 (4.15) 5.52 (4.02) <0.01
Ethnicity (no., %) 0.51
Chinese 171 (73 %) 36 (64 %)
Malay 43 (18 %) 14 (25 %)
Indian 19 (8 %) 6 (11 %)
Others 2 (1 %) 0 (0 %)
Stroke classification (no., %) 0.39
SAO 112 (48 %) 23 (41 %)
LAA 30 (13 %) 10 (18 %)
CE 33 (14 %) 11 (20 %)
UND 8 (3 %) 4 (7 %)
OC 1 (0.43 %) 0 (0 %)
TIA 51 (22 %) 8 (14 %)
NIHSS (median) 1.00 4.00 <0.01
Baseline mRS (median) 2.00 3.00 <0.01
Mean interval (Days) between stroke/TIA and assessment (mean, SD) 2.62 (2.09) 4.02 (3.05) <0.01
Cognitive screening test
Baseline MoCA (mean, SD) 22.36 (4.26) 14.75 (4.13) <0.01
Baseline NINDS-CSN 5-minute protocol (mean, SD) 9.29 (2.25) 6.41 (2.46) <0.01
Number of cardiovascular risk factors (median) 3 3 0.14
Recurrent vascular events 3–6 months (no., %) 10 (4 %) 2 (4 %) 1.00
Recurrent vascular events 1-year (no., %) 4 (2 %) 2 (4 %) 0.54
VCI vascular cognitive impairment, SD standard deviations, SAO small artery occlusion, LAA large artery atherosclerosis, CE cardioembolism, UND undetermined
etiology, OC other determined etiology, TIA transient ischemic attack, NIHSS National Institute of Health Stroke Score, mRS modified rankin scale, MoCA Montreal
Cognitive Assessment
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screening at baseline or 3–6 months after stroke. Add-
itionally, the NINDS-CSN 5-minute test protocol was
developed based on expert opinion without empirical
evidence [5]. The MoCA test items sensitive to cognitive
pattern of “subcortical deficits” (bradyphrenia, frontal-
executive and visuospatial deficits), such as visuo-
executive items (Trails B, Cube, Clock) and working
memory item such as Serial 7 s, that may improve
screening accuracy are not included in the NINDS-CSN
5-minute test. Therefore future studies should develop
an abbreviated MoCA test based on empirical evidence
and validate it through independent administration of
this abbreviated MoCA against a gold standard neuro-
psychological battery for bedside screening of VCI. Fur-
thermore, the utility of longitudinal changes of the
MoCA, NINDS-CSN 5 minute test and the empirically
derived short MoCA may be examine for clinical
practice.
Conclusion
In conclusion, MoCA administered sub-acutely during
stroke admission and 3–6 months after stroke has
Table 2 Discriminant indices of MoCA and NINDS-CSN 5-minute protocol in detectingmoderate-severe VCI at 1-year
MoCA NINDS-CSN 5-minute protocol
CUT-OFF SEN SPEC PPV NPV ACC CUT-OFF SEN SPEC PPV NPV ACC
(A) Baseline
21/22 0.95 0.62 0.37 0.98 0.68 9/10 0.79 0.54 0.29 0.91 0.59
20/21 0.93 0.69 0.42 0.98 0.74 8/9 0.77 0.66 0.35 0.92 0.68
19/20a 0.88 0.75 0.46 0.96 0.78 7/8a 0.73 0.75 0.41 0.92 0.75
18/19 0.80 0.81 0.50 0.95 0.81 6/7 0.63 0.83 0.47 0.90 0.79
17/18 0.70 0.84 0.51 0.92 0.81 5/6 0.43 0.95 0.69 0.88 0.85
(B) 3–6 months
22/23 0.91 0.68 0.40 0.97 0.72 9/10 0.81 0.64 0.35 0.93 0.67
21/22 0.89 0.74 0.45 0.97 0.77 8/9 0.74 0.77 0.43 0.92 0.76
20/21a 0.83 0.80 0.50 0.95 0.81 7/8a 0.70 0.83 0.49 0.92 0.80
19/20 0.68 0.87 0.55 0.92 0.83 6/7 0.49 0.94 0.65 0.89 0.85
18/19 0.64 0.91 0.64 0.91 0.86 5/6 0.25 0.98 0.72 0.84 0.84
aOptimal cut-off score
MoCA Montreal Cognitive Assessment, NINDS-CSN National Institute of Neurological Disease and Stroke-Canadian Stroke Network, SEN sensitivity, SPEC specificity,
PPV positive predicted value, NPV negative predicted value, ACC correctly classified rate
Fig. 1 Baseline MoCA and NINDS-CSN 5-min protocol ROC curves for
detecting moderate-severe VCI at 1-year. Solid line represented the ROC
curve for MoCA, while the dashed line represented the ROC curve for
NINDS-CSN 5-min protocol
Fig. 2 Three to six months MoCA and NINDS-CSN 5-min protocol ROC
curves for detecting moderate-severe VCI at 1-year. Solid line represented
the ROC curve for MoCA, while the dashed line represented the ROC
curve for NINDS-CSN 5-min protocol
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significantly higher sensitivity and is superior to the
NINDS-CSN 5-minute protocol in predicting moderate-
severe VCI at 1 year.
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Additional file 1: Table S1 Cognitive domains and individual tests on
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